No Data
No Data
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Vaccine Stocks Drop on Concerns About RFK Jr. Heading HHS
Bavarian Nordic Reports Results for First Nine Months; Reaffirms Upgraded Guidance for FY24
BAVARIAN NORDIC SPON ADR EA REPR 0.3333 ORD(BVNRY.US) will release its financial report on November 15th.
Bavarian Nordic sponsored ADR representing 0.3333 shares (BVNRY.US) will release its financial report on November 15th, investors are advised to pay attention. How was the previous performance? Bavarian Nordic sponsored ADR representing 0.3333 shares (BVNRY.US) had revenue of 1.427497 billion DKK, net income of 0.261128 billion DKK, and earnings per share of 1.1 DKK in 2024/Q2. Revenue in Q3 2023
First Mpox Case Linked to African Outbreak Reported in U.K.
Bavarian Nordic Said to Have Won $63M Mpox Vaccine Contract From U.S.